https://www.thebodypro.com/category/meeting-costs-hiv-care

Meeting the Costs of HIV Care

The Latest

Advances in HIV Science Must Not Leave Needs of People Behind, Experts Urge Img
African-Americans

Advances in HIV Science Must Not Leave Needs of People Behind, Experts Urge

As the 2019 National HIV Prevention Conference kicked off on March 18, plenary speakers discussed not only recent biomedical advances, but also what is truly needed in heavily affected U.S. communities to end the epidemic.

Staying on PrEP is Significantly Different for PrEP Users With Commercial Insurance Versus Medicaid Img
News

Staying on PrEP is Significantly Different for PrEP Users With Commercial Insurance Versus Medicaid

Young adults, blacks, cisgender women, and people in rural areas, as well as people on Medicaid, were less likely to persist on PrEP.

the corporate factor
People Who Use Drugs

Pharma Payments to Doctors Associated With Spike in Opioid Deaths, New Study Reveals

After years of anecdotes and speculation, harm reduction and pharma watchdog advocates have data to back claims that the spike in opioid deaths in the U.S. can be tied to pharmaceutical companies marketing highly addictive opioids to doctors.

Promo Image
News

This Week in HIV Research: Do We Need New Statin Guidelines?

Cholesterol guidelines may underestimate statin value; shifting from Ryan White CARE Act to Affordable Care Act coverage; HCV seroconversion and CD4 count suppression; HCV reinfection odds by risk group.

Promo Image
News

This Week in HIV Research: The Case for Pre-Pregnancy Treatment

The benefits of pre-pregnancy HIV treatment initiation for mothers-to-be; HIV diagnoses rise among young U.S. MSM; cost effectiveness of PrEP for heterosexual women; methotrexate and arterial function.

California: A Health Care Laboratory With Mixed Results Img
California

California: A Health Care Laboratory With Mixed Results

A report on HIV patients is one example showing that though the state is often a national beacon in health care, some of its innovations fall short of expectations.

The DMV Balenciaga House Meeting
Hepatitis C

With Only 15% of Diagnosed HCV Patients Receiving Treatment, the Non-Profit I-MAK Hopes to Shift the National Conversation on Drug Pricing

The Initiative for Medicines, Access and Knowledge, Inc. (I-MAK) argues that the high price of hepatitis C cure medicines places them out of reach for most people.

Promo Image

This Week in HIV Research: Erectile Dysfunction in the Modern Age

Reductions in erectile function among men who have sex with men; Australia, San Francisco, and 90-90-90 “fast track” targets; hepatitis C infection and HIV risk; safety of the live herpes zoster vaccine.

Insurers and Pharmas Must Help Fix HIV Drug Pricing System, Advocates Say Img
CROI (Conference on Retroviruses and Opportunistic Infections)

Insurers and Pharmas Must Help Fix HIV Drug Pricing System, Advocates Say

The Fair Pricing Coalition is working with pharmaceutical companies to ensure fair prices for new HIV drugs on par with those of older medications.

HIV Prevalence Among Non-Medicaid Expansion States
CROI (Conference on Retroviruses and Opportunistic Infections)

Separate and Unequal Access Frames Discussion at CROI Panel on U.S. HIV Care Cascade

The lack of Medicaid expansion in the South is creating worse racial disparities in the U.S., according to researchers and medical providers discussing the HIV care cascade at CROI 2018.